Blood Analysis: New Horizons in Interpretation for the Diagnosis of Complex Diseases

From Routine Analysis to Molecular Blood Interpretation

A complete blood count (CBC) is traditionally one of the most common and informative diagnostic tools. It allows for the assessment of the quantity and condition of the main cellular elements of the blood—red blood cells, white blood cells, and platelets—as well as hemoglobin and hematocrit levels. These basic indicators help physicians detect anemia, inflammatory processes, infections, and blood clotting disorders. However, modern medical science is going much further, offering a deep "interpretation" of blood analysis at the molecular level.

Today, blood is viewed not only as a carrier of cells but also as a source of a vast array of genetic, protein, and metabolic information. Cutting-edge research utilizes bioinformatics, multi-omics analysis (the study of the genome, transcriptome, proteome, and metabolome), and single-cell analysis to identify specific biomarkers. These methods allow for the detection of subtle changes in gene expression and immune cell profiles, which opens new possibilities for early diagnosis, prognosis of disease progression, and the development of personalized treatment approaches for complex diseases [1, 2, 4, 5, 6, 8].

Cardiovascular Diseases: Genes, Immunity, and New Risks

Cardiovascular diseases remain one of the leading causes of mortality worldwide. Modern research shows that their development is closely linked to immune dysregulation and complex molecular mechanisms that can be identified through blood analysis.

• Atrial Fibrillation (AF): This is a common arrhythmia associated with immune system disorders [1]. Bioinformatic studies have identified key genes, such as LBH, C8orf4, INPP5A, and CH, which play a role in the development of AF, potentially serving as a basis for new therapeutic targets [1]. Furthermore, the presence of complex aortic plaques is an important risk factor for stroke in patients with AF [7]. Existing coronary risk assessment scales can be adapted to identify an increased likelihood of AF in patients with chronic coronary syndrome (CCS) [3].
• Acute Myocardial Infarction (AMI): This is one of the leading causes of mortality [5]. When combined with chronic kidney disease (CKD), AMI exhibits specific molecular, microbial, and metabolic characteristics. Studies have identified four common candidate genes—PTPRC, ITGAL, CD44, and SELL—which showed preliminary discriminative ability and were positively correlated with an increase in immune cell subsets [2]. Multi-omics analysis and machine learning are actively used to search for new biomarkers and therapeutic targets for AMI [5].
• Coronary Artery Disease (CAD): Research is focused on identifying biomarkers in peripheral blood. For example, HIST1H2AE and CXCL14 are being considered as potential epigenetic markers for CAD [6]. It has also been established that CAD and metabolic syndrome share common diagnostic biomarkers, indicating their close interrelationship [8].

Inflammatory Bowel Diseases: Transcriptomic Markers

Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, are chronic conditions that require precise diagnosis and monitoring. Analysis of intestinal transcriptomic data (the study of gene expression) allows for the identification of molecular markers specific to these diseases [4].

During research, genes such as C2, NLRC5, S100P, PGAP3, and GPR15 were identified, showing potential as diagnostic biomarkers for IBD. Specifically, the NLRC5 and C2 genes demonstrated high diagnostic efficacy, which could lead to the development of more accurate and non-invasive diagnostic methods for these diseases [4].

Innovative Interpretation Methods: Multi-omics and Machine Learning

To perform a deep "interpretation" of blood analysis and understand complex pathological processes, advanced technologies are used:

• Multi-omics Analysis: Integrating data from various "omics" disciplines (genomics, transcriptomics, proteomics, metabolomics, microbiomics) provides a comprehensive view of biological processes in the body. For example, in studies of AMI combined with CKD, stool samples (for 16S rRNA microbiota sequencing) and blood serum (for metabolomics) were analyzed [2].
• Bioinformatics and Machine Learning: These tools are indispensable for processing and analyzing massive volumes of data. They are used to identify differentially expressed genes (DEGs), perform functional enrichment (Gene Ontology/Kyoto Encyclopedia of Genes and Genomes), assess immune cell infiltration (e.g., using the CIBERSORT algorithm), and identify key "hub genes" [1, 2, 4, 5, 6, 8]. Methods such as LASSO regression, random forest (RF), and weighted gene co-expression network analysis (WGCNA) help select the most significant biomarkers [1, 4, 5, 8].
• Use of Databases: Researchers actively use public gene expression databases (e.g., Gene Expression Omnibus – GEO) and genetic association databases (GWAS, eQTL) to discover and validate biomarkers [1, 2, 4, 5, 6, 8].

Perspectives of Personalized Medicine

These scientific advancements in the "interpretation" of blood analysis pave the way for personalized medicine. Understanding individual molecular profiles of patients allows not only for more accurate and earlier diagnosis of diseases but also for the development of targeted treatment methods, maximally adapted to the specific individual. In the future, routine blood analysis will likely be supplemented by deep molecular screening, which will significantly increase the effectiveness of prevention and treatment for a multitude of diseases.

Sources

1. Identification of key genes and immune mechanisms in atrial fibrillation: An observational bioinformatics and single-cell transcriptome study. https://pubmed.ncbi.nlm.nih.gov/42071886/
2. Multiomics Analysis Identifies Candidate Molecular, Microbiota, and Metabolite Features Associated with Acute Myocardial Infarction Combined with Chronic Renal Failure. https://pubmed.ncbi.nlm.nih.gov/42267897/
3. Repurposing Coronary Risk Scores to Identify Increased Likelihood of Atrial Fibrillation in Chronic Coronary Syndrome. https://pubmed.ncbi.nlm.nih.gov/42029585/
4. Integrative Analysis of Intestinal Transcriptomes Underscores C2 Upregulation in IBD, AIG, EoE, and CRC. https://pubmed.ncbi.nlm.nih.gov/42559028/
5. Identification of key biomarkers for myocardial infarction by multi-omics analysis and machine learning. https://pubmed.ncbi.nlm.nih.gov/42051519/
6. Peripheral Blood HIST1H2AE is a Candidate Epigenetic Biomarker for Coronary Artery Disease: A Multi-Dataset Discovery and Comparative Validation Study. https://pubmed.ncbi.nlm.nih.gov/42011357/
7. Ultrasonographic frequency of complex aortic plaques in patients with atrial fibrillation. https://pubmed.ncbi.nlm.nih.gov/42265643/
8. Shared diagnostic biomarkers in metabolic syndrome and coronary artery disease identified by integrated bioinformatics and machine learning. https://pubmed.ncbi.nlm.nih.gov/42160392/

The information provided in this article is for reference purposes only and cannot replace consultation with a qualified medical professional. Always consult a physician for diagnosis and treatment.